NM_006308.3:c.2T>C
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PVS1_SupportingBS2
The NM_006308.3(HSPB3):c.2T>C(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,461,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006308.3 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000796 AC: 20AN: 251172Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135746
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461648Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727142
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neuronopathy, distal hereditary motor, type 2C Uncertain:1
This sequence change affects the initiator methionine of the HSPB3 mRNA. The next in-frame methionine is located at codon 104. This variant is present in population databases (rs769845878, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with HSPB3-related conditions. ClinVar contains an entry for this variant (Variation ID: 1019333). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at